Table:
begin	end	state
1	20	cytoplasmic
21	48	transmembrane
49	59	non-cytoplasmic
60	79	transmembrane
80	90	cytoplasmic
91	111	transmembrane
112	117	non-cytoplasmic
118	137	transmembrane
138	148	cytoplasmic
149	171	transmembrane
172	176	non-cytoplasmic
177	197	transmembrane
198	254	cytoplasmic
255	276	transmembrane
277	294	non-cytoplasmic
295	315	transmembrane
316	322	cytoplasmic
323	339	transmembrane
340	344	non-cytoplasmic
345	369	transmembrane
370	382	cytoplasmic
383	402	transmembrane
403	407	non-cytoplasmic
408	431	transmembrane
432	452	cytoplasmic

Input:
>BPHYT_RS30250 FitnessBrowser__BFirm:BPHYT_RS30250
MNRSTAVNVQTFINEHPFSPFQWLVFFMCFIIVLLDGFDTAAIGFIAPSLIAEWGITRPA
LAPVLSAALFGLACGALGSGPLSDRLGRRSLLLGSVLLFGVACLGSAFSTSIEQLTTLRF
ITGVGLGAAMPNAVTMMGEYCPDRRRATVINLMFCGFPLGAAFGGFLAAWMIPHFGWRSV
LLLGGITPLLLLIVLAIKMPESVRYMVANNKPVERIRAALARISSEAAQAGSFVMTETAP
QTGGKGMAVVLSRSYIIGSVMLWIAYFMGLVIFYASINWMPILLKDAGLTPQRATLISAL
FPLGGVGAVLCGVLMDRFNANRIIAACYALTAVSVYFIGQAVGNVGALVFIVFVAGVLMN
TAQSSMPALAAAFYPTEGRGTGVAWMLGIGRFGGIAGSFLVAELTRRHFSFAGIFAMVAV
AGLLACLALLIKQAARPHVANVGAPKAESFGH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server